Gabapentin use in hyperemesis gravidarum: A pilot study

Thomas Guttuso; Luther K. Robinson; Kofi S. Amankwah

doi:10.1016/j.earlhumdev.2009.11.003

Gabapentin use in hyperemesis gravidarum: A pilot study

Thomas Guttuso
, Luther K. Robinson
, Kofi S. Amankwah

SUNY Buffalo

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Abstract

Among 7 subjects with hyperemesis gravidarum (HG), we found gabapentin therapy to be associated with mean reductions in nausea and emesis from Baseline to Days 12-14 of 80% and 94%, respectively. There have been 2 congenital defects among 7 exposed infants. Gabapentin may be effective in the treatment of HG.

Original language	English
Pages (from-to)	65-66
Number of pages	2
Journal	Early Human Development
Volume	86
Issue number	1
DOIs	https://doi.org/10.1016/j.earlhumdev.2009.11.003
State	Published - Jan 2010

Keywords

Gabapentin
Hyperemesis
Morning sickness
Nausea
Pregnancy
Vomiting

Access to Document

10.1016/j.earlhumdev.2009.11.003

Cite this

@article{b233ac6079e140c5be95ee56b62acb6e,

title = "Gabapentin use in hyperemesis gravidarum: A pilot study",

abstract = "Among 7 subjects with hyperemesis gravidarum (HG), we found gabapentin therapy to be associated with mean reductions in nausea and emesis from Baseline to Days 12-14 of 80\% and 94\%, respectively. There have been 2 congenital defects among 7 exposed infants. Gabapentin may be effective in the treatment of HG.",

keywords = "Gabapentin, Hyperemesis, Morning sickness, Nausea, Pregnancy, Vomiting",

author = "Thomas Guttuso and Robinson, \{Luther K.\} and Amankwah, \{Kofi S.\}",

year = "2010",

month = jan,

doi = "10.1016/j.earlhumdev.2009.11.003",

language = "English",

volume = "86",

pages = "65--66",

journal = "Early Human Development",

issn = "0378-3782",

publisher = "Elsevier Ireland Ltd",

number = "1",

}

TY - JOUR

T1 - Gabapentin use in hyperemesis gravidarum

T2 - A pilot study

AU - Guttuso, Thomas

AU - Robinson, Luther K.

AU - Amankwah, Kofi S.

PY - 2010/1

Y1 - 2010/1

N2 - Among 7 subjects with hyperemesis gravidarum (HG), we found gabapentin therapy to be associated with mean reductions in nausea and emesis from Baseline to Days 12-14 of 80% and 94%, respectively. There have been 2 congenital defects among 7 exposed infants. Gabapentin may be effective in the treatment of HG.

AB - Among 7 subjects with hyperemesis gravidarum (HG), we found gabapentin therapy to be associated with mean reductions in nausea and emesis from Baseline to Days 12-14 of 80% and 94%, respectively. There have been 2 congenital defects among 7 exposed infants. Gabapentin may be effective in the treatment of HG.

KW - Gabapentin

KW - Hyperemesis

KW - Morning sickness

KW - Nausea

KW - Pregnancy

KW - Vomiting

UR - https://www.scopus.com/pages/publications/77649190607

U2 - 10.1016/j.earlhumdev.2009.11.003

DO - 10.1016/j.earlhumdev.2009.11.003

M3 - Article

C2 - 20015600

AN - SCOPUS:77649190607

SN - 0378-3782

VL - 86

SP - 65

EP - 66

JO - Early Human Development

JF - Early Human Development

IS - 1

ER -

Gabapentin use in hyperemesis gravidarum: A pilot study

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this